The 
INTRODUCTION
The future of biochemistry lies in understanding how single gene products associate and function together. Interactions in connective tissues, including those between the proteoglycans and collagens are especially piquant, evolutionarily conserved and physiologically significant.
Connective tissues (e.g. skin, tendon, blood vessels, etc.) are systems of insoluble fibrils and soluble polymers which evolved to take the stresses of movement and the maintenance of shape [1] . The fibrils resist pulling forces, and the interfibrillar soluble polymers resist compressive forces, like the stuffing in a cushion. Cells communicate biochemically through the soluble polymer compartment. Within this simple framework, multicelled organisms developed [1] .
It was often speculated that there were specific associations between fibrils and soluble polymers. These ideas were extremely general, lacking chemical knowledge of the participants, and methods for diagnosing interactions. The situation now tends to the other extreme. Sensitive methods discover many 'specific' liaisons -in vitro. Even when these are observed at physiological pH, temperature and ionic strength, caution is needed. The very large polymers characteristic of connective tissues (collagens, proteoglycans etc.) have enormous surfaces, because of their shapes, with great potential for interactions. Interactions are not functionally significant if the participants are not placed in vivo so that they can interact. This review is weighted towards cases where interactions were seen in tissues.
THE PARTICIPANTS
The collagens, comprising at least 12 different gene products [2, 3] , contain large amounts of hydroxyproline (< 17 %), glycine (< 33 %) and proline. They are classified simply, types I-XII. Type I is the commonest. Many tissues (e.g. tendon, sclera, bone) contain little of any other. Like types II and III it is a thread-like molecule consisting of three similar polypeptides (the a chains, -105 Da), in a triple helix about 300 nm long. They aggregate in 'quarter stagger' arrays, with about 75 % of each molecule in contact with its neighbours, ahead and behind ( Fig. 1 ). This form is determined by the amino acid sequences of the a-chains, that come together to maximize hydrophobic and charge attractions between them [4] . Because of periodicity in the polypeptides, with glycine at every third residue, and a high incidence of sequences such as Gly-Pro, the fibrillar aggregates (stained with UO22+ etc.) show periodic features in electron micrographs, as repeating patterns of dark bands, designated a-e (Fig. 1 ). According to a simple model, the part of the fibril containing the gap between the ends of the collagen molecules (hence the 'gap zone', where bands d and e are located) alternates with the 'overlap' zone (where band b is located) with bands a and c at the 'step' to the 'gap' zone ( Fig. 1) .
Collagen types I, II, III, V and XI form fibrils [5] . Types I and III can coexist in the same fibril [6] , and some 'minor' collagens probably associate with fibrillar collagens (e.g. type V with type I in the cornea [7] , type IX with type II [8] ). Type VIII collagen, in Descemet's membrane [9] , may also form fibrillar or branched fibrillar structures. Collagens are biosynthesized as procollagens, which are processed extracellularly by proteolytic cleavages at the N-and C-terminals before they can aggregate efficiently to fibrils. There are thus a number of stages at which collagens might interact with proteoglycans, from procollagen, through various aggregates, to the complete fibril. The first stages are in solution, the later interactions are surface phenomena.
The proteoglycans, the soluble polymers in the simple scheme of connective tissues, above, consist of a polypeptide 'core', to which is attached one or more glycan chains [10] [11] [12] . The glycan chains are of three types, (1) heparan, (2) keratan, and (3) chondroitindermatan. They consist of repeating disaccharide units, one residue of which is always hexosamine, usually with sulphate ester groups attached at the 4 or 6 positions.
(1) Heparans contain D-glucuronic and L-iduronic acid in varying proportions, and glucosamine, either as 2-deoxy-2-acetamido-or 2-deoxy-2-sulphamato-glucose. [72] . The latter method is not as convincing with the keratan sulphate proteoglycans, which are present in somewhat similar amounts, as with the dermatan sulphate proteoglycans, which are present in very different concentrations [72] . The numbering of the dermatan sulphate bands was originally reversed [72] and [93, 101] , in error (cf. text of [72] ). Results on keratan sulphate and dermatan sulphate proteoglycans were from type I collagen rich tissues (see the text), and the relevant fibrils were therefore probably of type I collagen. The chondroitin sulphate proteoglycan interactions were observed in annulus fibrosus [92] which contains much type II collagen, and it is not known whether the relevant fibrils were type I or II.
' small', 'large' and 'very large' (Fig. 2) . Rotary shadowing electron microscopy brings out the salient features [15] [16] [17] .
(1) The 'small' proteoglycans, globular proteins with one or two glycan chains, are tadpole-like.
(2) 'Large' proteoglycans have at least one globular region, with a linear polypeptide extension, to which are attached five to ten glycosaminoglycan chains.
(3) 'Very large' proteoglycans, particularly those from cartilage, have up to three globular regions attached to a long polypeptide chain, to which are attached up to 100 glycan chains.
Many small proteoglycans have similar amino acid compositions [18] , tryptic peptide maps, and cross-react with antibodies [19] . Some amino acid sequences have been determined, mainly by DNA techniques (e.g. [20] [21] . A 'large' proteoglycan has been isolated containing both chondroitin sulphate and heparan sulphate [22] .
Summary. The diversity of structures among collagens and proteoglycans implies a very large number of potential interactions. ' In vitro' investigations have only scratched the surface of the many possibilities. One proteoglycan-collagen association is well defined: Type IX collagen contains covalently linked glycosaminoglycan [23] [24] [25] [26] . ' [31] . None of the glycosaminoglycan-collagen or glycosaminoglycan-gelatin results depart from expected behaviour. Data obtained at low pH are of limited functional significance and will not be discussed ( [32] , reviews early work). Interactions of isolated glycosaminoglycans with collagens probably occur seldom in normal tissues, but are significant in analysing the more complex proteoglycan-collagen interaction.
Solutions of intact fibril-forming collagens at physiological pH and ionic strength are used at low temperature, to avoid spontaneous fibril formation (fibrillogenesis), which occurs quickly at 37°C [33] . The influence of glycosaminoglycans and proteoglycans on fibrillogenesis is a complicated but functionally relevant way of detecting glycosaminoglycan-proteoglycan interactions with collagen ( [34] , and see below). Collagen without non-helical peptides aggregates less readily, but the data obtained are of restricted interest.
Problems of aggregation were avoided by using affinity supports with collagen, or parts thereof, as the ligand. Solutions of glycosaminoglycan, proteoglycan etc. were applied and eluted under appropriate conditions. Various supports were used; e.g. CNBr-Sepharose [35, 36] , agarose [37, 38] , or collagen itself, cross-linked with glutaraldehyde [39] , as reconstituted fibrils [40] , or as the insoluble residue from exhaustively extracted tissues [32] . The state of aggregation and spatial arrangement of collagen molecules in most preparations were unknown, rendering detailed interpretations difficult.
Solutions of interactants have been examined by light scattering [41] or electric birefringence [42] .
Binding regions on both molecules may be recognized by electron microscopy, after rotary shadowing [43] or positive staining [44] .
Results
Glycosaminoglycan-coliagen interactions are electrostatic, since they are abolished by raising the salt concentration. This criterion is not as clear as often assumed; it shows only that there is an electrostatic component, and that remaining bonding(s) cannot hold the components together at ambient temperature.
The salt concentration required to prevent interactions differs according to the system. Potential confusion arises from the way results were expressed. Some [37, 39] treated immobilized collagen as a gel, from which a kind of binding constant was derived, whereas others [36] saw it as an ion exchanger from which polyanion eluted at characteristic salt concentrations. The former method can demonstrate weak binding at high salt concentrations.
Hyaluronan interacted feebly or not at all with collagen at physiological pH and ionic strength [32, 41] . Neither Vol. 252 did keratan sulphate [41] . Chondroitin sulphate and heparan sulphate did not bind to reconstituted collagen fibrils under physiological conditions [40] , whereas heparin interacted strongly in all systems [39] [40] [41] . Thus, glycosaminoglycan linear change density is important. Heparan sulphate of low Mr but high sulphation was more active than one with high Mr and low sulphation [41] .
Mathews [32] [45] .
Iduronate-rich glycosaminoglycans (dermatan sulphate and heparan sulphate) were more active at comparable size [41, 46] . Such glycosaminoglycans are potentially more interactive than glucuronate analogues, because of secondary structures in the latter [47] .
It is difficult to derive association energies from these results. In principle, the binding constants [37] Fibrillogenesis is strongly affected by glycosaminoglycans [33, 34] . Wood & Keech [34] dissected the process into a nucleation (or lag) phase and a growth phase. They demonstrated effects, originating in one phase or the other, on fibril morphology. The biological interest and attractive simplicity of these ideas led to much use of the system in diagnosing and comparing interactions of glycosaminoglycans and proteoglycans with collagens.
The terms 'precipitation' and 'fibrillogenesis' have often been used interchangeably. Precipitation (or coacervation) of most proteins with glycosaminoglycans and proteoglycans occurs at low pH and low ionic strength [48] , whereas banded fibril formation is characteristic of only some collagens. In non-physiological conditions collagen precipitates in non-banded forms [49] and it is better to reserve 'fibrillogenesis' for those systems in which fibrils undoubtedly form. Fibrillogenesis is more complicated, and sensitive to as yet unidentified factors, than the early analysis suggests.
Chondroitin sulphate and keratan sulphate had little effect on nucleation or growth [33, 34, 49, 50, 51] . Hyaluronan speeded up both stages, possibly by excluded volume effects [41, 49, 51] that increased activity of collagen [41] , but neither keratan sulphate, nor chondroitin sulphate at much higher concentrations behaved similarly [41] , and the hyaluronan effect may be more subtle and specific.
Glycosaminoglycans which interacted strongly with collagen at 4°C (dermatan sulphate, heparan sulphate [41, 46] and heparin at low concentrations [41] ) accelerated nucleation.
Proteoglycans did not behave according to the 'simple' glycosaminoglycan experience. Although large cartilage chondroitin sulphate proteoglycans were without effect [49, 52] or decelerated [50, 51, 53, 54] growth, they were incorporated into the type I collagen 'precipitate' [50, 51, 53] . The glycosaminoglycan chains chondroitin sulphate [50, 51] and dermatan sulphate [51] were not, nor were they incorporated into Type II collagen fibrils [55] . Chondroitin sulphate proteoglycan was incorporated only if it was present during, but not after, fibril formation [50] . The bound proteoglycan was not in equilibrium with solution proteoglycan, and tended to be lost to the solution with time.
These results suggest that glycosaminoglycans and some proteoglycans might be 'squeezed out' of their complexes with collagens by other collagen molecules during aggregation. Such a mechanism would explain why no glycosaminoglycan chains were found in collagen precipitates, although typically two to five chains of glycosaminoglycan were associated per molecule of collagen in solution [46] . A similar mechanism may operate during growth in vivo (see below).
Cartilage chondroitin sulphate proteoglycans without chondroitin sulphate (by chondroitinase digestion) but with residual keratan sulphate, bound strongly to Type I collagen [38, 50, 56] and Swarm sarcoma proteoglycan, which contains no keratan sulphate, still bound to collagen after removal of chondroitin sulphate [50] . Digestion with papain, Pronase etc. [50, 56] completely destroyed binding. These results point to a core-protein association with collagen. Nevertheless, the core-protein was unable to inhibit chondroitin sulphate proteoglycan binding [50, 56] suggesting either separate binding sites for the two species, or strong binding of chondroitin sulphate proteoglycan, perhaps due to co-operation between chondroitin sulphate chains and the protein core.
It is not clear whether 'aggregated' chondroitin sulphate proteoglycan does [50] or does not [52, 53] inhibit fibril formation rates.
Small dermatan sulphate proteoglycans, like the very large cartilage chondroitin sulphate proteoglycans, are incorporated into Type I collagen precipitates [44, 51, 57] and inhibit fibril growth in vitro [36, 51] ( [54] , dermatan sulphate proteoglycan from tendon). Dermatan sulphate proteoglycan (skin) protein core associates with, and inhibits fibrillogenesis [36, 54] . Antibody staining and electron microscopy demonstrated binding of the protein core to reconstituted type I collagen fibrils [58] .
Results on other proteoglycans are few. A keratan sulphate proteoglycan from cornea did not bind to a type I collagen-Sepharose column [59] at 0.1 M ionic strength. A mammary epithelial cell heparan sulphate proteoglycan bound strongly to reconstituted type I collagen fibrils at higher-than-physiological salt concentrations [40] . Heparan sulphate chains did not bind under these conditions, but heparin inhibited heparan sulphate proteoglycan binding.
Collagens other than type I interact with proteoglycans and glycosaminoglycans, e.g. type II [54] [55] [56] , and the Ia,2az,3a-collagen from cartilage [60] . The very large cartilage chondroitin sulphate proteoglycan interacted with the latter (both as fibrils and in solution) with high avidity. Heparin, dextran sulphate and chondroitin sulphate competed in binding, but chondroitinasedigested chondroitin sulphate proteoglycan did not (cf. chondroitin sulphate proteoglycan-type I collagen interactions, above).
Type IV collagen-heparan sulphate proteoglycan interactions have been much investigated with reference to basement membrane structure (see [61] and [62] for recent reviews). Summary and consensus of findings from model experiments (1) Glycosaminoglycans interact electrostatically with type I collagen under physiological conditions. Additional short range bonding cannot be excluded. Linear charge density is important, as is glycosaminoglycan shape (determined by iduronate: glucuronate ratios).
(2) Strongly interacting glycosaminoglycans accelerate fibrillogenesis.
(3) Glycosaminoglycans are not incorporated into types I and II collagen fibrils.
(4) Chondroitin sulphate and dermatan sulphate proteoglycans interact strongly with type I collagen, electrostatically via glycosaminoglycan chains, and by protein-protein interactions.
(5) Chondroitin sulphate and dermatan sulphate proteoglycans are incorporated into type I collagen precipitates, if present during fibril growth.
(6) Chondroitin sulphate and dermatan sulphate proteoglycans inhibit fibrillogenesis.
Available data are insufficient to establish differences between type I and other fibrillar collagens. The influence of telopeptides on interactions is not yet clarified, and work on the morphology of fibrils produced in the presence of glycosaminoglycans or proteoglycans is incomplete.
TISSUES General
The co-occurrence in tissues of particular glycosaminoglycans and collagens might imply interaction between them [63] . As the number of identified glycosaminoglycans, proteoglycans and collagens rises rapidly, this inference is unreliable.
The ease of extraction of proteoglycans from tissues is a rough guide to the strength of binding to collagen. Since most are extractible in 4 M-guanidinium chloride, covalent links are excluded, but interactions of lesser energy are not easily distinguished from entrappment and entanglement. Very mild methods (water, mechanical disintegration) used to extract, e.g., hyaluronan from many tissues, chondroitin sulphate proteoglycan from cartilage, etc.), imply weak or negligible bonding.
Ultrastructural methods, which inform in biochemical terms at molecular resolutions, that were developed in the last 10 years, are based on X-ray diffraction [64] [65] [66] , n.m.r. [67] , but mainly on electron histochemistry [68] .
Whereas collagen fibrils are insoluble permanent structures, proteoglycans are soluble, invisible and swollen, in aqueous environments. Routine embedding in plastic for electron microscopy, involving dehydration through organic solvents, precipitates them randbmly. In many tissues (skin, tendon, etc.) proteoglycans occur in relatively small amounts (< 1.0% w/w). It is therefore necessary to (a) render the proteoglycans visible (i.e. stain them) preferably specifically [69, 70] , (b) retain their molecular morphology, as far as possible [68] and (c) fix the proteoglycans vis-a-vis fibrils, cells and other molecules, so that the stained artefact is interpretable in terms of molecular interactions.
Staining reagents were classified as macro-and mini-, to emphasize important aspects of their application [68] . Macro-stains (mainly antibodies and derivatives) penetrate tissues poorly, often do not stain stoicheiometrically, have inferior resolution at the molecular level, but are usually specific and sensitive. Mini-stains (e.g. dyestuffs, UO+, etc.) penetrate tissues easily, produce images of high resolution, stain stoicheiometrically, are convenient, flexible and cheap, but lack specificity. Their high resolution has been crucially important in identifying proteoglycan binding sites (Fig. 1) . Antibodies are particularly useful in staining proteoglycan protein cores, whereas mini-stains are best in demonstrating glycosaminoglycan sidechains. The two kinds of reagent are complementary, rather than alternatives [68] .
The specificity of mini-reagents is improved by using them in the critical electrolyte concentration mode [68] [69] [70] . This principle is fundamental to polyelectrolyte fractionation using ion exchangers. Cationic staining reagents have similar resolving power to, e.g., QAEor DEAE-cellulose [69, 71] . If the reagent is designed to have low affinity for nucleic acids (e.g. Alcian Blue, Cupromeronic Blue [68, 69] ) the critical electrolyte concentration approach ensures that few tissue polyanions stain. With the further help of keratanase or chondroitinase AC, most glycosaminoglycans are identifiable [72] .
Staining (i.e. precipitation) with cationic reagents collapses the polyanion domain [68] . The shape and size of the staining molecule determines the extent and direction of this collapse: the reagent acts as a scaffold to the polyanion, in the stained complex. By tailoring the dye, optimum electron density was achieved compatible with retention of recognizable shapes of the tissue proteoglycans [68] . Results
Patterns of proteoglycan-coliagen fibril interaction in tissues. Using bismuth at low pH, stained artefacts were sometimes seen on collagen fibrils, distributed approximately D-periodically, possibly at the a-band [73] . Later investigators, using a variety of cationic reagents on a number of tissues, claimed localization to the a band [74] , d band [75] or 'between a and d bands' [76] . The apparent discrepancies were due to variations between tissues and methods [77] . Pictures improved with the use of Alcian Blue in* critical electrolyte concentration methods [78, 79] , and again with Cuprolinic Blue and Cupromeronic Blue [70, 77, 80] . Using the Cupromeronic Blue/critical electrolyte concentration approach, with tungstate as an 'intensifier' [70] , proteoglycans were visualized with high contrast as filaments of varying.
morphologies [70] , easily located with respect to a-e bands stained with 2 With this technique [81] tissues rich in type I collagen were systematically studied. Very regular arrays of proteoglycan filaments, orthogonal to the collagen fibrils and spaced D-periodically, were observed in tendons [68, 70, 77] (Fig. 3) , sclera [82] and skin [83] . Filaments Vol. 252 were found at the d band, or less frequently at the e band, i.e. in the gap zone (Fig. 1 ). This distribution was not an artefact of dehydration and plastic embedding, since, using synchotron X-ray diffraction, a similar pattern was obtained from wet, stained tendon before processing for electron microscopy [65] . Other proteoglycans were seen parallel to the fibril, at its surface, exactly spanning the gap between adjacent D-spaced proteoglycan filaments [70, 82] (Fig. 3) . Still others, of varying length and thickness, were seen between (or on) the collagen fibrils [77, 84] . Biochemical analyses and resistance to hyaluronidase digestion indicated that the orthogonal proteoglycan was dermatan sulphate-rich, in skin, sclera [83] and tendon [77] . In all three tissues, there are 'large' chondroitin sulphate proteoglycans (i.e. low in iduronate) and 'small' dermatan sulphate proteoglycans [85] [86] [87] [88] . Thus orthogonal proteoglycans at the gap zone of type I collagen fibrils were small dermatan sulphate proteoglycans [77] . Less direct evidence suggested that interfibrillar, unspecifically located proteoglycans could be large chondroitin sulphate-dermatan sulphate proteoglycans'' [89] . They are more easily extracted than small dermatan sulphate proteoglycans [18] . Immunostaining of skin [90] placed the small proteoglycan at the surface of collagen.fibrils (which per se does not prove collagen association, since the precipitated antibody complexes must come to rest on some kind of support [68] ), or more specifically, in the vicinity of the gap zone [58] .
Dermatan sulphate is derived from chondroitin sulphate, by epimerization at glucuronate C-5, after the glycan chain has formed. The percentage epimerized varies, from around 30 % in cornea [21] and cartilage [91] to over 80 % in skin and sclera. The relevant dermatan sulphate proteoglycans still locate at the gap zone. In rabbit annulus fibrosus, chondroitinase AC-sensitive proteoglycan (i.e. a chondroitin sulphate proteoglycan) appears as complete hoops about the collagen fibril at the d-e bands [92] . The collagen was not identified. It was suggested that this proteoglycan was similar to the small dermatan sulphate proteoglycans (Fig. 2) , by analogy with the small chondroitin sulphate proteoglycan of cartilage [15] , and that epimerization to dermatan sulphate was not initiated [92, 93] .
Gap-zone-associated proteoglycans were seen in human cartilage [94] . Neither the collagen nor the proteoglycan was identified. Smail chondroitin sulph-ate [95] and dermatan sulphate proteoglycans [91] -as well as types I and II collagen [96] are found in cartilage. Hyaluronidaso digestioe. completely-removed the. orthe-
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gonal, gap-zone-associated proteoglycans (J. E. Scott & M. Haigh, unpublished work).
Corneal stroma is rich in type I collagen, and in dermatan sulphate and keratan sulphate, which are present in separate proteoglycans [21] . After keratanase digestion, dermatan sulphate proteoglycan was seen at the d and e bands, as in skin, etc. [83] . Removal of dermatan sulphate by chondroitinase ABC digestion left keratan sulphate proteoglycan, located at the a and c bands. Keratan sulphate was readily isolable from bovine, rabbit and rat corneas, but not from mouse cornea [97, 98] .-Accordingly, mouse corneal stroma proteoglycans were not seen at the a/c bands, but only at the d/e bands. These proteoglycans were keratanaseresistant and chondroitinase ABC-sensitive, i.e. they were chondroitin sulphate-dermatan sulphate containing [97, 98] .
Corneal proteoglycans are important in keeping the fibrils apart, at-regular spacings, for transparency [99, 100] . Nevertheles4, mouse cornea is fully functional in the absence of keratan sulphate [98] .
A map of proteoglycan binding sites on the collagen fibril, based on these results [83, 93, 101] (Fig. 1 ) embodies two important concepts: (1) that each proteoglycan has its specific binding site, and (2) that in the absence of this proteoglycan, the site is not occupied. The richest source of type I collagen is bone. Electron microscopical study of bone organic matrix requires prior removal of the electron-dense mineral. Demineralization in organic solvents retained the proteoglycan [102] , which was seen as an integral part of the matrix, but distributed parallel to the fibrils [83] . The major bone proteoglycans contain chondroitin sulphate, rather than dermatan sulphate [83, 103] in small proteoglycans similar to those discussed above [103] .
The absence of gap-zone-associated proteoglycan in bone, and its presence in non-mineralizing tissue, suggested an inhibitory role for some small tadpoleshaped dermatan sulphate and chondroitin sulphate proteoglycans during calcification [77, 83, 93] . The gap zone was claimed to be the site of nucleation of calcification [104] . The powerful Ca2 -binding properties of dermatan sulphate (or chondroitin sulphate) [105] at this site could hardly be without effect on nucleation. In calcifying turkey tendon the orientation of gap-zoneassociated proteoglycan filaments changed from orthogonal to axially parallel, as the calcification front moved along the tissue (J. E. Scott & M. Haigh, unpublished work). These phenomena may be secondary to the calcification process, but it is relevant that of two osteoblast cell lines, isolated from the same tissue, one which made calcified matrix could not express small chondroitin sulphate proteoglycan, while the other, which did not calcify, could [106] .
In spite of strong indications from model experiments (see above) that it can interact with collagen, the very large chondroitin sulphate proteoglycan of cartilage has not been seen in structures similar to those mapped in Fig. 1 [68, 107] . This may be because of the huge scale of the proteoglycan molecule, which, coupled with the thinness of the ambient collagen fibrils, requires that many clusters of chondroitin sulphate chains be located against a poorly defined frame of reference. The situation in cartilage is complicated by the presence of small proteoglycans, which may be responsible for observed orthogonal arrays (see above).
13C-n.m.r. spectra of chondroitin sulphate were obtained from pieces of cartilage [67] , implying that chondroitin sulphate chains were freely mobile, since if they were tied down by interactions to collagen, n.m.r. spectra could not have been observed. The specific associations summarized in Fig. 1 were at the fibril surface. The ratio of tissue concentrations of regularly placed fibril-surface associated species X to collagen, [X]/[Coll], should be proportional to d-' where d is the average diameter of the cylindrical collagen fibrils [89] , providing all of X were at the fibril surface, i.e.
[X] = [XJ. Dermatan sulphate in developing tendons from chick, rat and cow obeyed this relationship, whereas chondroitin sulphate and hyaluronan in the same tissues did not [89, 108] . The combined inaccuracies of measurement of the three parameters was such that significant amounts of glycosaminoglycan might not be so distributed. More complicated distribution patterns than those of the simple model are conceivable, which nevertheless produce the same relationships. {e.g. if Xs were in equilibrium with interfibrillar X (XI) so that
Not all a, c, d, e bands were occupied. Considerable amounts of unassociated proteoglycan lay between the collagen fibrils, in proteoglycan-rich tissue such as young tendon or cornea [70] . There may thus be an equilibrium between bound and free proteoglycans [101] . Other explanations are conceivable until equivalence or otherwise of the bound and free proteoglycan is established.
Notwithstanding, the biochemical morphometric conclusions were compatible with those from electron histochemristry [89] .
Intrafibrillar artefacts, very probably proteoglycans, were stained in ultrathin plastic sections [109] or with Cupromeronic Blue before embedding ( [101] , Fig. 4) . With a critical electrolyte concentration of 0.3 MMgCl2, the latter must be sulphated proteoglycan. They were of uniform length (about 0.5-0.7 D, 30-50 nm long) and spanned the gap region. They may be surface proteoglycans which were incorporated into the fibril, e.g. by overlaying of collagen molecules, or by fusion of fibrils [84] . Alternatively, they might be type IX collagen (which has attached glycosaminoglycan [23] [24] [25] [26] ), an integral part of the fibril structure. They were seen in tendon, demineralized rat femur, human and rabbit intercostal cartilage [101] (Fig. 4) .
MECHANISMS OF INTERACTION IN THE TISSUES
Specifically located proteoglycans are usually intimately associated with collagen fibrils. Thus, other molecules (fibronectin, etc.) do not necessarily mediate the interaction, although model systems suggest the possibility [110] .
There are at least two modes of association: (1) orthogonal and (2) glycan molecule could interact with one to four collagen molecules, each of 1.5 nm diameter.
(2) Axially parallel interactions in many tissues (see above) need involve only one collagen molecule per interaction. Often, only a part of the length of a collagen molecule is engaged. In tendons [70] (Fig. 3 ) and annulus fibrosus [92] peripheral axial proteoglycans are commonly 1 D unit long, i.e. about 25 % of the length of a collagen molecule.
Further interpretation of the pictures is not possible, since the detailed relationship of the electron microscopic image to the proteoglycan molecule has not been worked out. The stain must be associated electrostatically with the glycosaminoglycan chain, but the contribution of the protein core to the image is unclear. Subject to this proviso, pictures of an in vitro model [44] suggest that the dermatan sulphate chain may not be involved in the interaction, except at one end, which may be the protein core region.
Additional arguments for a proteoglycan-proteincollagen interaction are:
(a) the d/e bands are not cationic [76] , and hence would not be preferred as dermatan sulphate binding sites [77] ; (b) despite considerable change in the dermatan sulphate glucuronate: iduronate ratios the relevant proteoglycans still bind to d/e bands (Fig. 1); (c) if dermatan sulphate was responsible for the specificity of association, the d and e bands should be occupied equally, and not, as is usual, mainly the d band [77, 83] ; (d) similarly, unequal occupancy of a/c bands by keratan sulphate proteoglycans [72, 98] would be unexpected, if only keratan sulphate was responsible for binding; (e) in the rabbit cornea, the tissue concentration of each kind of dermatan sulphate proteoglycan correlates with the percentage occupancy of d and e bands [72, 98] ; (f) similarly, there is a correlation between percentage occupancy of the a/c bands, and tissue concentrations of keratan sulphate proteoglycans, which differ in their protein cores [72, 98] (but see legend to Fig. 1 ).
FIBRIL RADIAL GROWTH
In embryonic tissues, collagen fibrils grow in an environment rich in hyaluronan and/or proteoglycans [84, 112] . Correlations between fibril nucleation in vivo Markedly periodic orthogonal proteoglycan association occurs at the heavily stained banding region (analogous to the gap zone complex of c, d, e, a), rather than to the lightly stained region, which compares with the overlap zone in Fig. 1 . To this extent, the proteoglycan-collagen fibril interaction is very similar to that mapped in Fig. 1 (x 150000) . and proteoglycan-hyaluronan interactions, although possible, are not proved.
The very thin fibrils of fetal tendons showed D-periodic proteoglycan attachment [70] , and dermatan sulphate proteoglycan was present [84] . There was a striking transition from a chondroitin sulphate/ hyaluronan-rich tendon to one containing predominantly dermatan sulphate, when the collagen-fibrils began to expand rapidly, at the time of first muscle loading [84, 108] . Before this the collagen fibrils were of thin uniform diameter and very regularly spaced. Cross sections of immature tendon fibres showed remarkable similarity to mature cornea. Correlations between thin collagen fibrils and hyaluronan and/or chondroitin sulphate proteoglycan abundance were made [84, 113] and extended to other tissues.
The presence of high concentrations of hyaluronan/ proteoglycan may control the radial expansion, and possibly the fusion, of collagen fibrils [84, 113, 114] .
Fibrils grow radially in vivo, even though proteoglycan is present at the fibril surface, during normal development, implying that collagen molecules compete with and displace proteoglycan molecules from the surface.
Fusion of fibrils may take place, with displacement of surface-bound proteoglycan [84] . The model experiments (above) hint at how this could occur. Proteoglycans were incorporated into fibrils in vitro, during growth, and inhibited the rate of growth. There was a tendency to lose (chondroitin sulphate) proteoglycan from the complex, and once the fibril formed, proteoglycan binding was limited [50] . A picture similar in some respects to those from tissues (Fig. 3) , with D-periodically associated (dermatan sulphate) proteoglycan at the fibril surface, was obtained in vitro [44] .
Fibril radial growth may cease (apart from fusion) at the end of development because the supply of collagen monomers ceases [115] .
EVOLUTIONARY ASPECTS
The association between collagen and proteoglycans has been evolutionarily conserved, as implied by the constancy of dermatan sulphate-collagen relationships in three species [89] .
Very primitive animals contain collagens and proteoglycans [116] similar to those present in man, birds, Vol. 252 321 etc. Fig. 5 shows a proteoglycan-collagen binding pattern in holothurian (sea cucumber) tissue like that in rat tail tendon [70] , rabbit skin [83] etc. The glycosaminoglycan is based on chondroitin sulphate, but with sulphated fucose residues attached to the glucuronic acid (H. Z. Fan & J. F. Kennedy, unpublished work). A second polysaccharide, polyfucose sulphate, is also present in the tissue [117, 118] .
Thus, in spite of major differences in the glycans, and probably the collagens, the regular association of proteoglycan with collagen fibrils remains, confirming the fundamental importance of these proteoglycancollagen interactions throughout evolution.
